Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
BIOFIDELITY LTD has 2 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 2 distinct examiners and 2 distinct art units, giving the portfolio a distributed examination structure despite its limited pending workload.
GIAMMONA, FRANCESCA FILIPPA is the busiest examiner, with 1 pending matter. Counsel should account for the separate examination channels when aligning claim amendments, technical explanations, and response timing across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.3% | +58.8% |
| CROW, ROBERT THOMAS | 1 | 41.6% | +32.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18259192 | IMPROVED POLYNUCLEOTIDE SEQUENCE DETECTION METHOD | CROW, ROBERT THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546473 | METHODS FOR POLYNUCLEOTIDE DETECTION | GIAMMONA, FRANCESCA FILIPPA | — |
| 18259192 | IMPROVED POLYNUCLEOTIDE SEQUENCE DETECTION METHOD | CROW, ROBERT THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546473 | METHODS FOR POLYNUCLEOTIDE DETECTION | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103§112DPOther | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18259192 | IMPROVED POLYNUCLEOTIDE SEQUENCE DETECTION METHOD | CROW, ROBERT THOMAS | 1683 | §103§112Other | Non-Final OA | — | Pending | Jun 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBIOFIDELITY LTD has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Francesca Filippa Giammona has the most, with 1 of BIOFIDELITY LTD's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
